Isohemagglutinin titration in pooled and apheresis platelets
Transfusion · 2024
DOI: 10.1111/trf.17873 ↗At a glance
Journal article in Transfusion, 2024. Written by QingYun Hua and 9 co-authors. Institution: Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. Major MEDLINE topics: Platelet Transfusion, ABO Blood-Group System, Blood Platelets, Plateletpheresis. 29 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Background
Platelet inventory constraints necessitate ABO‐incompatible platelet transfusion. Many minimize the hemolytic impact by confirming low titre (LT) donor isohemagglutinins. This process is costly. Pathogen‐reduced platelets (PRP) in platelet additive solutions (PAS) will dilute plasma and decrease high‐titre isohemagglutinins (HT). We determined the proportion of HT platelets and incompatible transfusions for units suspended in plasma to reassess the need for titres following introduction of PRP/PAS. Study Design and Methods Our titre method is manual tube (1:50) dilution of platelet supernatant from apheresis or whole blood derived buffy coat pools suspended in plasma, tested with A1/B red cells. Testing included 49,058 pooled and 11,738 apheresis platelets over 4 years. The HT proportion, rate of out‐of‐group transfusions, and hemolytic reactions were determined. The impact of PAS dilution was estimated.
Results
Totally 60,796 platelet units were tested. Group O pooled and group B apheresis platelets had HT in 6.6% and 5.7%, respectively. Group A pooled and apheresis platelets included 2% with HT. Approximately 25% of platelets transfused were ABO‐incompatible and no hemolytic reactions were reported. Based on the proportions of PAS‐E and plasma for PRP platelets, plasma from each donor comprises 11 mL (6% of total volume) vs 20‐257 mL in untreated pools. PAS‐E will replace and dilute residual plasma by at least 50%.
Discussion
Rare platelet pools may demonstrate HT. PRP platelets with PAS will reduce titres and may abrogate the need for titration. A strategy of group specific transfusion or transfusion of group A PRP platelet transfusions may be a safe alternative.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
- Transfusion & Transplantation Medicine Program, Alberta Precision Laboratories, Edmonton, Alberta, Canada.
ORCID profiles: QingYun Hua
Cite
APA
Hua, Q., Lyon, B. W., Duke, J., Felske, A., Hobbs, K., Holman, R., Radwi, G., Sidhu, D., Clarke, G., & Nahirniak, S. (2024). Isohemagglutinin titration in pooled and apheresis platelets. Transfusion. https://doi.org/10.1111/trf.17873
Vancouver
Hua Q, Lyon BW, Duke J, Felske A, Hobbs K, Holman R, et al. Isohemagglutinin titration in pooled and apheresis platelets. Transfusion. 2024. doi:10.1111/trf.17873
BibTeX
@article{Hua2024,
author = {Hua, QingYun and Lyon, Bruce W and Duke, Jennifer and Felske, Amanda and Hobbs, Karen and Holman, Ryan and Radwi, Ghazala and Sidhu, Davinder and Clarke, Gwen and Nahirniak, Susan},
title = {Isohemagglutinin titration in pooled and apheresis platelets},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.17873}
}
EUVIMED